EMA to keep closer tabs on supplies of all approved Covid-19 vaccines and therapeutics
The European Medicines Agency on Wednesday released a new list of critical medicines to battle the ongoing pandemic, which will put the market authorization holders for these Covid-19 vaccines and drugs on the hook for regularly updating the EMA with data on potential or actual shortages and available stocks, forecasts of supply and demand.
European Member States also will have to provide regular reports on estimated demand for these critical medicines on the national level. The list includes vaccines from Pfizer/BioNTech, Moderna, Novavax, J&J, and AstraZeneca, as well as drugs like dexamethasone, Pfizer’s Paxlovid, Gilead’s remdesivir, and other monoclonal antibodies from AstraZeneca, Regeneron, Roche and others.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.